首页> 外文OA文献 >Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

【2h】

Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

机译：PANCALYZE试验方案：一项多中心，前瞻性研究，研究了切除的胰腺腺癌患者中的肿瘤生物标记物CXCR4，SMAD4，SOX9和IFIT3，以预测疾病的复发方式

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease [J] . Felix C. Popp, Marie Christine Popp, Yue Zhao, BMC Cancer . 2017,第1期

机译：PANCALYZE试验的方案：一项多中心，前瞻性研究，研究了胰腺癌切除患者的肿瘤生物标志物CXCR4，SMAD4，SOX9和IFIT3，以预测疾病的复发方式
2. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma [J] . BachetJ.B., MaréchalR., DemetterP., Annals of oncology: official journal of the European Society for Medical Oncology . 2012,第9期

机译：CXCR4和SMAD4在预测胰腺癌切除过程中疾病进展模式和辅助化疗获益中的作用
3. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma [J] . J. B. Bachet1234*† R. Maréchal4† P. Demetter5 F. Bonnetain6 A. Couvelard7 M. Svrcek18 A. Bardier-Dupas19 P. Hammel10 A. Sauvanet11 C. Louvet11213 F. Paye114 P. Rougier215 C. Penna216 J. C. Vaillant117 T. André13 J. Closset18 I. Salmon5 J. F. Emile219 and J. L. Van Laethem4 Annals of Oncology . 2012,第9期

机译：CXCR4和SMAD4在预测胰腺癌的疾病进展模式和辅助化疗获益中的作用
4. Protocol of the PANCALYZE trial: a multicenter prospective study investigating the tumor biomarkers CXCR4 SMAD4 SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease [O] . Felix C. Popp, Marie Christine Popp, Yue Zhao, 2017

机译：PANCALYZE试验方案：一项多中心前瞻性研究研究了切除的胰腺腺癌患者中的肿瘤生物标记物CXCR4SMAD4SOX9和IFIT3以预测疾病的复发方式
5. The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study [O] . Sang Hyun Shin, Hwa Jung Kim, Dae Wook Hwang, 2017

机译：DPC4 / SMAD4遗传状态决定了切除的胰腺导管腺癌中的复发模式和治疗结果：一项潜在的队列研究

Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

著录项

相似文献

相关主题

期刊订阅